Article
A microRNA diagnostic biomarker for amyotrophic lateral sclerosis
1 Jan 2024
Abstract excerpt
Abstract Blood-based diagnostic biomarkers for amyotrophic lateral sclerosis will improve patient outcomes and positively impact novel drug development. Critical to the development of such biomarkers is robust method validation, optimization and replication with adequate sample sizes and neurological disease comparative blood samples. We sought to test an amyotrophic lateral sclerosis biomarker derived from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
